Aprea Therapeutics, Inc.

Q4 2019 13F Holders

Symbol
APRE
CUSIP
03836J102
Type
Equity
Class
COM
Num filers
40
Total reported value, excl. options
$591M
Manager Report Date Value ($000) Shares Option Type